Fact check.
1 meeting in April and 2nd meeting in June. How is that 3 meetings since April. Obviously there were some questions unanswered. Being a first for this type of equipment it’s going under the microscope of queries. There is nothing to compare it to, so release is cautiously regarded.
Novel and first to market.
Everybody believes that the USA is so technologically advanced, but having travelled there several times and many other continents as well, they are so far behind Asia for instance, they are still coming to terms with AI.
FDA is supported by Pharma, this device reduces the usage of Pharma. Conflicted judgement? Anybody’s guess.
I personally believed it would be approved this time round.
i think we and the market believed.
patience will be rewarded. Just a bit longer than anticipated.
Great chance to buy below 5c.
And if there is another CR. I’ll be buying my quota without hesitation.
Cheers to more good news from all the other irons in the fire!
DYOR
Add to My Watchlist
What is My Watchlist?
